Find clinical trials for Prostate Cancer in Seattle, WA
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Prostate Cancer trials near Seattle, WA, USA:
androgen deprivation therapy (ADT) with a luteinising hormone releasing hormone analogue (LHRHA) in men having radiation therapy for localised prostate...
Phase 3
Seattle, Washington, United States and 92 other locations
purpose of this study is to assess the safety, tolerability, and preliminary efficacy of BMS-986460 in men with Metastatic Castration-resistant Prostate...
Phase 1
Seattle, Washington, United States and 7 other locations
This is a phase 1 study to assess the safety and tolerability of ARX517 in adult subjects with Metastatic Castration-Resistant Prostate Cancer...
Phase 1
Seattle, Washington, United States and 8 other locations
inhibitor, in Veterans with metastatic castration-resistant prostate cancer (mCRPC) characterized by either mismatch repair deficie...
Phase 2
Seattle, Washington, United States and 11 other locations
Evaluate the safety and tolerability of AMG 509 in adult participants and determine the maximum tolerated dose (MTD) or recommended phase 2 dose (RP2...
Phase 1
Seattle, Washington, United States and 50 other locations
radiation therapy for patients with intermediate-high risk localized prostate cancer. ProstAtak kills tumor cells and stim...
Phase 3
Gig Harbor, Washington, United States and 72 other locations
of vudalimab (XmAb20717) alone or in combination with standard of care anticancer therapies in patients with metastatic castration-resistant prostate...
Phase 2
Seattle, Washington, United States and 25 other locations
clinical efficacy in participants with metastatic hormone-sensitive prostate cancer (mHSPC) by progression-free survival.The resear...
Phase 2
Seattle, Washington, United States and 29 other locations
open-label clinical trial of the VTP-850 prime-boost immunotherapeutic in men with biochemical recurrence after definitive local therapy for prostate...
Phase 1, Phase 2
Seattle, Washington, United States and 6 other locations
the safety and preliminary antitumor activity of ORIC-944 as a single agent and in combinations with ARPIs in patients with metastatic prostate...
Phase 1
Seattle, Washington, United States and 15 other locations
Clinical trials
Research sites
Resources
Legal